GSK1059615 has been used in trials studying the treatment of Lymphoma, Solid Tumours, Endometrial Cancer, Solid Tumor Cancer, and Metastatic Breast Cancer.
Molecular Weight:
333.36
Purity:
99.30%
CAS Number:
[958852-01-2]
Formula:
C18H11N3O2S
Target:
mTOR|||Apoptosis|||PI3K
T2357
* VAT and and shipping costs not included. Errors and price changes excepted